Trial Profile
Phase III randomized placebo-controlled double blind comparative study to investigate the efficacy and safety of DA-9501 in sedation during the surgery with epidural anesthesia or spinal anesthesia without intubation under monitored sedation care
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Sponsors Hospira; Pfizer
- 30 Mar 2014 New trial record